Latest News for: inms

Edit

InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds (Form 8-K) (InMed Pharmaceuticals Inc)

Public Technologies 22 Jan 2025
InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds ● Marks the first jurisdictional issuance of an international patent for a family of novel small molecule compounds ... Vancouver, BC - January 22, 2025 - InMed Pharmaceuticals Inc.
Edit

Inmed's INM-901 Demonstrates Statistically Significant Reduction In Neuroinflammation In A Long-Term Preclinical Alzheimer's Disease Study

MENA FN 21 Jan 2025
(MENAFN - Newsfile Corp) INM-901 significantly reduced pro-inflammatory cytokines associated with Alzheimer's Statistically significant reduction in neurodegeneration marker, neurofilament light ... .
Edit

InMed’s INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer’s Disease Study (Form 8-K) (InMed Pharmaceuticals Inc)

Public Technologies 21 Jan 2025
InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study ● INM-901 significantly reduced pro-inflammatory cytokines associated with Alzheimer's.
Edit

Cbdnewsbreaks Inmed Pharmaceuticals Inc. (NASDAQ: INM) Reports On Promising Results From Study On INM-089 Treatment ...

MENA FN 10 Jan 2025
(MENAFN - Investor Brand Network) InMed Pharmaceuticals (NASDAQ. INM) , a leader in the research, development, manufacturing and commercialization of rare cannabinoids and proprietary cannabinoid ... .
Edit

Cbdnewsbreaks Inmed Pharmaceuticals Inc.'S (NASDAQ: INM) Baymedica Poised As Rare Cannabinoids Drive Market Growth

MENA FN 10 Jan 2025
(MENAFN - Investor Brand Network) InMed Pharmaceuticals' (NASDAQ. INM) subsidiary BayMedica is positioned amid a growing interest in edibles infused with non-intoxicating minor cannabinoids. These ... .
Edit

Inmed Pharmaceuticals Inc. (NASDAQ: INM) Releases Favorable Results From INM-901 Preclinical AD Studies

MENA FN 03 Jan 2025
(MENAFN - Investor Brand Network). InMed Pharmaceuticals (NASDAQ. INM) , a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, ... .
Edit

Supplemental Prospectus (Form 424B3) (InMed Pharmaceuticals Inc)

Public Technologies 02 Jan 2025
Our common shares are listed on the Nasdaq Capital Market under the symbol "INM" ... InMed's INM-901 is a proprietary small molecule, disease modifying drug candidate that is being developed as a potential treatment for Alzheimer's disease.
Edit

Amendment to Initial Registration Statement (Form S-1/A) (InMed Pharmaceuticals Inc)

Public Technologies 30 Dec 2024
2.1 Amended and Restated Agreement and Plan of Reorganization, dated as of October 13, 2021, by and among InMed Pharmaceuticals Inc., InMed LLC, BayMedica, Inc., BM REP, LLC, as the stockholder ...
Edit

Statement of Changes in Beneficial Ownership (Form 4) (InMed Pharmaceuticals Inc)

Public Technologies 23 Dec 2024
OMB Number ... 2 ... InMed Pharmaceuticals Inc. [INM] 5 ... C/O INMED PHARMACEUTICALS INC., 1445-885 WEST GEORGIA ST ... C/O INMED PHARMACEUTICALS INC ... (2) On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis ... InMed Pharmaceuticals Inc.
Edit

Initial Registration Statement (Form S-1) (InMed Pharmaceuticals Inc)

Public Technologies 23 Dec 2024
InMed's INM-901 is a proprietary small molecule, disease modifying drug candidate that is being developed as a potential treatment for Alzheimer's disease.
Edit

Initial Registration Statement for Employee Benefit Plan (Form S-8) (InMed Pharmaceuticals Inc)

Public Technologies 20 Dec 2024
INMED PHARMACEUTICALS INC ... InMed Pharmaceuticals Inc ... InMed Pharmaceuticals Inc ... (the "Company"), for allotment under the InMed Pharmaceuticals Inc ... 4.2 InMed Pharmaceuticals Inc ... INMED PHARMACEUTICALS INC ... InMed Pharmaceuticals Inc.
Edit

InMed Announces Results of 2024 Annual General Meeting Form 8 K (InMed Pharmaceuticals Inc)

Public Technologies 19 Dec 2024
INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, ...
Edit

InMed Enters Into Standby Equity Purchase Agreement Form 8 K (InMed Pharmaceuticals Inc)

Public Technologies 18 Dec 2024
INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, ...
Edit

InMed Announces Publication of Study on Anti Inflammation by Modulation of Endocannabinoid System Form 8 K (InMed Pharmaceuticals Inc)

Public Technologies 20 Nov 2024
INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, ...

Most Viewed

×